Glycogene Inc
Share
Glycogene INC (Glycogene) is an advanced biotechnology enterprise founded in April 2019.
07/28/2023
Monoclonal antibody drug conjugate (ADC) is a complex formed by coupling cytotoxic drugs with monoclonal antibodies through linkers. ADC drugs consist of three parts: antibodies, linkers, and chemical drugs.
The selection of targets and the quality of antibodies determine the affinity of ADC to tumor cells; The type of linker determines the stability of the drug; The choice of chemical drugs determines the lethality and side effects of ADC.
www.glycogene.com
04/07/2023
Glycogene attended World Vaccine Congress in Washington DC.
12/13/2022
Glycogene is at 5th RNA-Targeted Drug Discovery Summit. We look forward to seeing you in Boston Park Plaza! See you in our booth.
www.glycogene.com
11/30/2022
Welcome to our booth, 5th RNA-Targeted Drug Discovery Summit. Glycogene looks forward to seeing you in Boston Park Plaza!
www.glycogene.com
11/10/2022
Glycogene attended 10th International mRNA Health Conference
www.glycogene.com
Click here to claim your Sponsored Listing.
